William Poon

William is an Senior Associate Scientist in the NGS group at Strand Therapeutics. His research interests have enabled him to explore the intersection of single-cell transcriptomics and CRISPR-Cas9 to decipher the intrinsic aging mechanisms in murine hematopoietic stem cells, where he developed a lentiviral-based CRISPR-Cas9 pipeline to gene-edit primary hematopoietic stem and progenitor cells. Separately, he conducted genome-wide CRISPR screens in acute myeloid leukemia models to identify chemosensitizer vulnerabilities. He has also built a solid foundation in cell sorting, flow cytometry, and molecular biology techniques. Outside of academia, William has worked in the field of synthetic biology at Lallemand in the National Research Council of Canada, where he optimized the production process of metabolites within yeast systems. William completed his M.S. in Experimental Medicine at McGill University and B.S. in Biochemistry at the University of British Columbia.